Steven Cohen’s Crescent Biopharma CBIO Stock Holding History

Steven Cohen’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.4M	Hold	300,000	–	–	0.01%	1704
2026 Q1	$5.51M	Hold	300,000	–	–	0.01%	1637
2025 Q4	$3.56M	Buy	+300,000	New	+$3.82M	﹤0.01%	2079
2018 Q4	–	Sell	-1,850	Closed	-$2.66M	–	1059
2018 Q3	$2.66M	Buy	1,850 +50	+3%	+$75.6K	0.01%	718
2018 Q2	$2.9M	Buy	1,800 +530	+42%	+$911K	0.01%	712
2018 Q1	$2.06M	Buy	+1,270	New	+$2.64M	0.01%	730
2017 Q3	–	Sell	-2,923	Closed	-$3.26M	–	940
2017 Q2	$3.26M	Buy	+2,923	New	+$2.41M	0.02%	569

Other funds holding CBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Steven Cohen's CBIO Position: Q2 2026 in Review

Steven Cohen held its Crescent Biopharma (CBIO) position steady in Q2 2026 at 300,000 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #1704.

Steven Cohen first reported a position in CBIO in Q2 2017 and has held it in 7 quarters since. The position peaked at $5.51M in Q1 2026. 81 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.

Steven Cohen held 300,000 shares of Crescent Biopharma worth $5.4M as of Q2 2026.
Steven Cohen left its Crescent Biopharma share count unchanged in Q2 2026.
Crescent Biopharma made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1704 holding.
Steven Cohen first reported a position in Crescent Biopharma in Q2 2017 and has held it in 7 quarters since.
Steven Cohen's Crescent Biopharma position peaked at $5.51M in Q1 2026.
81 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.